Offering researchers an unrivaled range of preclinical contrast agents for small animal in vivo imaging. Bergisch Gladbach, Germany, and Berlin, Germany — Viscover marks the result of a fruitful collaboration between Miltenyi Biotec GmbH and nanoPET Pharma GmbH. Within this strategic alliance, Miltenyi Biotec is responsible for the distribution of Viscover products developed and manufactured […]
New contract a “significant win” for UK manufacturer Cleveland, UK – Leading research peptide manufacturer, Cambridge Research Biochemicals (CRB) announced today that it has been appointed by RCUK Shared Services Centre Ltd (RCUK SSC Ltd) as a key supplier of custom synthesised peptides and custom generated polyclonal and monoclonal antibodies. The new two-year contract will […]
Tools and Reagents Pre-Configured to Support Cell Therapy Clinical Translation CARLSBAD, Calif. — –LifeTechnologies Corporation (NASDAQ:LIFE) today announced the formation of GIBCO(R)Cell Therapy Systems (CTS(TM)), which will offer the life science industry’s widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from […]
Madison, WI USA — Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that […]
Liège, Belgium — Eurogentec is pleased to announce today that its majority shareholders have entered into an agreement with Kaneka by which the latter will acquire a majority stake in Eurogentec S.A. The Delwart Family remains on the Board of Directors as an important minority shareholder. Through this agreement, Eurogentec becomes the spearhead of Kaneka […]
Fully-validated SIRT1 Enhances Drug Discovery Investigation Wakefield, MA, and Worcester, MA — BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry’s only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully-validated in a label-free […]
SANTA ANA, Calif.–MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used […]
Lyon (France) — genOway (ALTERNEXT-NYSE EURONEXT: ALGEN; ISIN: FR0004053510), the biotechnology company dedicated to the development of genetically modified animal models, today announces strong growth of its business with major Japanese biopharmaceutical companies. The three Japanese biopharmaceutical companies, now customers of genOway, rank among the top ten of the nation’s biopharmaceutical industry. The amount of […]
COSTA MESA, Calif. — — DV Biologics LLC announced today that it has executed an agreement with System Biosciences LLC for the development of human-derived disease-specific induced pluripotent stem cell (iPSC) lines. iPSCs are pluripotent cells which are developed from non-pluripotent cells that have undergone gene expression changes to render them pluripotent giving them the […]
SAN DIEGO — — Cytori Therapeutics (NASDAQ: CYTX) entered into a $20 million secured loan facility from GE Capital, Healthcare Financial Services, Oxford Finance Corporation, and Silicon Valley Bank. The loan funded June 14, 2010. The funds will be used to support Cytori’s commercialization and clinical development activities in Europe, Asia and the United States. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
